Anxiety Disorder Clinical Trial
Official title:
Investigating Patterns in Enrollment and Engagement Among Individuals Coping With Anxiety Disorder
Clinical trials, specifically focused on anxiety disorder, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
| Status | Not yet recruiting |
| Enrollment | 500 |
| Est. completion date | December 2026 |
| Est. primary completion date | December 2025 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Aged = 18 years old - Diagnosis of anxiety disorder - Able to comprehend the investigational nature of the protocol and provide informed consent Exclusion Criteria: - Female patients who are currently pregnant or nursing - Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial. - Inability to perform regular electronic reporting |
| Country | Name | City | State |
|---|---|---|---|
| United States | Power Life Sciences | San Francisco | California |
| Lead Sponsor | Collaborator |
|---|---|
| Power Life Sciences Inc. |
United States,
Liao J, Kang J, Li F, Li Q, Wang J, Tang Q, Mao N, Li S, Xie X. A cross-sectional study on the association of anxiety and depression with the disease activity of systemic lupus erythematosus. BMC Psychiatry. 2022 Sep 5;22(1):591. doi: 10.1186/s12888-022-04236-z. — View Citation
Szuhany KL, Simon NM. Anxiety Disorders: A Review. JAMA. 2022 Dec 27;328(24):2431-2445. doi: 10.1001/jama.2022.22744. — View Citation
Yee A, Ng CG, Seng LH. Vortioxetine Treatment for Anxiety Disorder: A Meta-Analysis Study. Curr Drug Targets. 2018;19(12):1412-1423. doi: 10.2174/1389450118666171117131151. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of anxiety disorder patients who decide to enroll in a clinical research | 3 months | ||
| Primary | Rate of anxiety disorder patients who remain in clinical trial to trial completion | 12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
| Not yet recruiting |
NCT03224845 -
Courageous Parents, Courageous Children
|
N/A | |
| Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
| Completed |
NCT02145429 -
Preventing Depression in Late Life: A Model for Low and Middle Income Countries
|
N/A | |
| Completed |
NCT00794456 -
Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety
|
Phase 3 | |
| Terminated |
NCT00896467 -
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
|
N/A | |
| Completed |
NCT00252343 -
Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder
|
Phase 3 | |
| Not yet recruiting |
NCT05867823 -
OcupApp: Occupational Self-analysis Intervention Through an Mobile Application
|
N/A | |
| Recruiting |
NCT04562324 -
Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder
|
N/A | |
| Recruiting |
NCT05989451 -
Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders
|
N/A | |
| Not yet recruiting |
NCT05488418 -
Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56
|
N/A | |
| Not yet recruiting |
NCT03608449 -
Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System
|
N/A | |
| Completed |
NCT03400397 -
An Effectiveness Study of the Cool Kids Programme
|
N/A | |
| Completed |
NCT00025844 -
Fear Conditioning Using Computer-Generated Virtual Reality
|
N/A | |
| Completed |
NCT02579928 -
Ketamine Infusion for Adolescent Depression and Anxiety
|
Phase 4 | |
| Completed |
NCT02270073 -
The Process Outcome Mindfulness Effects in Trainees (PrOMET)-Study
|
N/A | |
| Terminated |
NCT03764644 -
Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders
|
N/A | |
| Completed |
NCT01721824 -
The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders
|
N/A | |
| Completed |
NCT01425619 -
The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests
|
N/A | |
| Completed |
NCT01227980 -
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
|
Phase 2 |